Definitive Contract 75A50223C00048
Award Date
9/20/23
Potential Completion Date
3/19/25
Potential Value
$21M
Awardee
Sekisui Diagnostics LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Burlington, MA 01803, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed price purchase order contract to Sekisui Diagnostics LLC, a foreign-owned for-profit manufacturer of goods. The contract has a potential value of $11,609.90 and a completion date of April 18, 2024. The contract is not set aside. Sekisui Diagnostics LLC provides a range of products and services related to healthcare and medical testing, including...
<p>The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, has awarded a $4,500,000.00 firm-fixed-price definitive contract to Genabio Diagnostics Inc. for the provision of over-the-counter (OTC) COVID-19 tests. The contract, which is not set aside, has an ultimate completion date of March 19, 2025. This contract award appears to be a standalone acquisition and not part of a larger vehicle.</p>
This is a $2,596,000.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The purpose of this firm-fixed-price contract is to procure over-the-counter (OTC) COVID-19 tests. The contract has an ultimate completion date of February 15, 2023 and was awarded on December 7, 2022. No set-aside designation was used for...
This is a $97,492,572.50 definitive, firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Quidel Corp, a manufacturer of medical diagnostics and supplies, for the procurement of over-the-counter (OTC) COVID-19 tests. The contract has an ultimate completion date of April 7, 2028 and does not use a set-aside designation. Quidel Corp, which is based in San Diego, California,...
<p>This is a $31,384,584.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Kwell Laboratories LLC, a minority-owned small disadvantaged business, for the delivery of over-the-counter COVID-19 tests. The contract has an ultimate completion date of March 19, 2025. The contract is not set aside and was awarded on September 20, 2023.</p>
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $5,746,950.00 firm-fixed-price definitive contract to Orasure Technologies Inc. for the delivery of over-the-counter (OTC) COVID-19 tests. The contract has a performance period through March 19, 2025 and was not set aside for any special business designation. Orasure, a manufacturer of diagnostic products including rapid tests for HIV, Ebola, and COVID-19, has been a...
This is a $236,090 firm-fixed-price federal contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Diasorin Inc., a foreign-owned for-profit organization. The contract is for the provision of Diasorin's LIAISON SARS-COV-2 S1/S2 IgG diagnostic testing products and services, including analyzers, reagents, test kits, controls, training, maintenance, and technical support. The contract is not designated as a set-aside. It...
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $88,704,000 definitive, firm-fixed-price contract to Access Bio, Inc. to provide over-the-counter (OTC) COVID-19 tests from September 2023 through March 2025. Access Bio is a minority-owned, for-profit, Asian-Pacific American-owned manufacturer of medical goods. This award is not associated with any set-aside program. Access Bio has previously received other...
This federal contract award, valued at $30,954,000.00, was made by the Office of the Assistant Secretary for Preparedness and Response to Diasorin Molecular, LLC, a foreign-owned, for-profit medical diagnostics manufacturer based in Cypress, California. The contract is a definitive, firm-fixed-price agreement with a period of performance extending through June 30, 2026. The purpose of this contract is to expand the availability of point-of-care molecular diagnostics in U.S. pharmacies....
The Department of Health and Human Services Indian Health Service awarded a firm fixed price delivery order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of COVID-19 testing kits (Cepheid 4PLEX XP3COV2 FLU RSV-10). The $204,000 award does not have a set-aside designation and is in support of the agency's Coronavirus COVID-19 response efforts. Cepheid, a subsidiary of Danaher Corporation, has a history of providing diagnostic testing equipment,...